Immuneering Income Statement (2020-2024) | IMRX

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Revenue & cost
Revenue 0.48M0.68M0.67M0.75M0.66M0.48M0.19M0.18M0.09M0.04M455.00
Cost of Revenue 0.26M0.32M0.47M0.41M0.32M0.22M0.21M0.09M0.05M0.02M
Gross Profit 0.23M0.37M0.19M0.34M0.34M0.26M-0.02M0.09M0.05M0.02M455.00
Operating items
Amortization - Intangibles 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Research & Development 2.82M4.07M4.89M5.39M6.99M6.21M7.95M9.06M7.98M9.36M9.87M10.21M9.45M10.05M11.91M
Selling, General & Administrative 0.64M0.70M1.14M1.18M1.34M2.60M3.15M3.95M3.70M3.84M4.11M4.46M4.04M3.87M4.38M
Other Operating Expenses 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Operating Expenses 3.47M4.77M6.03M6.58M8.33M8.81M11.10M13.02M11.69M13.21M13.99M14.68M13.50M13.93M16.30M
Operating Income -3.24M-4.40M-5.84M-6.24M-7.99M-8.54M-11.12M-12.93M-11.65M-13.19M-13.99M-14.68M-13.50M-13.93M-16.30M
EBIT -3.24M-4.40M-5.84M-6.24M-7.99M-8.54M-11.12M-12.93M-11.65M-13.19M-13.99M-14.68M-13.50M-13.93M-16.30M
Non-operating items
Non Operating Investment Income -0.00M-0.04M-0.12M-0.01M0.04M0.11M
Interest & Investment Income 0.04M0.00M518.000.01M0.00M0.02M0.14M0.13M0.14M0.22M0.52M0.83M1.17M0.86M0.75M
Other Non Operating Income -0.01M-0.12M-0.10M-0.02M0.12M0.22M0.24M0.15M0.48M0.46M
Non Operating Income -0.01M-0.12M-0.10M-0.02M0.12M0.22M0.24M0.15M0.48M0.46M
Net income details
EBT -3.20M-4.40M-5.84M-6.23M-7.99M-8.53M-10.97M-12.79M-11.50M-12.97M-13.47M-13.85M-12.34M-13.07M-15.55M
Profit After Tax -3.20M-4.40M-5.84M-6.23M-7.99M-8.53M-10.78M-12.90M-11.53M-12.84M-13.25M-13.60M-12.19M-12.60M-15.08M
Income from Continuing Operations -3.20M-4.40M-5.84M-6.23M-7.99M-8.53M-10.97M-12.79M-11.50M-12.97M-13.47M-13.85M-12.34M-13.07M-15.55M
Consolidated Net Income -3.20M-4.40M-5.84M-6.23M-7.99M-8.53M-10.97M-12.79M-11.50M-12.97M-13.47M-13.85M-12.34M-13.07M-15.55M
Income towards Parent Company -3.20M-4.40M-5.84M-6.23M-7.99M-8.53M-10.97M-12.79M-11.50M-12.97M-13.47M-13.85M-12.34M-13.07M-15.55M
Net Income towards Common Stockholders -3.20M-4.40M-5.84M-6.23M-7.99M-8.53M-10.97M-12.79M-11.50M-12.97M-13.47M-13.85M-12.34M-13.07M-15.55M
Additional items
EPS (Basic) -0.64-0.89-1.18-1.26-1.61-0.47-0.05-0.49-0.44-0.49-0.50-0.51-0.43-0.43-0.52
EPS (Weighted Average and Diluted) -0.64-0.89-1.18-1.26-1.61-0.47-0.05-0.49-0.44-0.49-0.50-0.51-0.43-0.43-0.52
Shares Outstanding (Weighted Average) 23.89M23.89M23.89M25.94M25.94M26.38M26.39M26.39M26.40M26.44M29.25M29.26M29.27M29.28M29.65M29.65M
Shares Outstanding (Diluted Average) 4.95M4.95M4.95M4.95M4.95M18.29M13.61M26.36M26.39M26.39M26.39M26.44M28.65M29.27M28.42M29.37M29.65M29.84M
EBITDA -3.24M-4.40M-5.84M-6.23M-7.99M-8.54M-10.83M-13.01M-11.54M-12.81M-13.13M-13.57M-12.19M-12.59M-15.09M